AI technology significantly reduces waiting time for cancer radiotherapy, improves accuracy, and protects healthy tissues. The UK National Health Service (NHS) provides this technology at cost price.
Recently, AI Magazine reported that the UK Department of Health and Social Care (NHS) has taken significant steps by allocating £21 million in funding for the implementation of AI technology within the NHS.
The main objective is to shorten the diagnosis time for patients, especially for life-threatening diseases.
Now, cutting-edge AI technology has become a breakthrough in cancer treatment, greatly reducing the waiting time for patients receiving radiotherapy.
This revolutionary technology, developed in collaboration between Addenbrooke Hospital and Microsoft researchers, is hailed as a major development in the field.
By improving the accuracy and efficiency of treatment with radiation beams, this AI program demonstrates promising results in targeting cancer cells while protecting healthy tissues.
In addition, the NHS has taken proactive action to provide this technology to all NHS trusts at cost price, allowing a wider range of patients to access it.
With the implementation of AI programs, doctors can accurately delineate the treatment area, optimizing the balance between destroying cancer cells and protecting healthy tissues.
Accelerating treatment plans
Traditionally, doctors spend a considerable amount of time manually analyzing hundreds of cross-sectional images, meticulously outlining organs and bones before starting radiotherapy.
This process can take anywhere from 25 minutes to 2 hours per patient.
However, the AI program developed through the collaborative efforts of Addenbrooke Hospital and Microsoft operates 2.5 times faster, significantly speeding up the treatment planning process.
Ensuring precise targeting of radiotherapy is crucial to minimize damage to nearby healthy tissues and organs.
For example, when treating prostate cancer, doctors strive to prevent damage to adjacent organs such as the bladder or rectum, which can lead to long-term urinary problems for patients.
Dr. Raj Jena, Chief Researcher at Addenbrooke Hospital, emphasizes the importance of avoiding such complications as they can significantly impact patients' quality of life and daily activities.
By implementing AI programs, doctors can accurately delineate the treatment area, optimizing the balance between destroying cancer cells and protecting healthy tissues.
Training artificial intelligence
To develop this groundbreaking technology, Dr. Jena collaborated with Microsoft and trained a program called InnerEye using data from previous patients.
This AI program underwent rigorous evaluation and safety checks and received £500,000 investment from the NHS AI Lab.
Subsequently, a manufacturer was granted access to this cloud-based technology, enabling other NHS trusts to benefit from it at cost price.
While the AI program plays a supportive role in treatment planning, it is important to note that doctors still review and validate the contours generated by AI.
However, the program demonstrates an astonishing accuracy rate of approximately 90%.
In many cases, clinical doctors approve the work generated by AI without the need for further corrections, indicating their trust and reliance on its capabilities.
Dr. Jena explains that some consultant colleagues are even more willing to start with the work generated by AI rather than relying solely on peer opinions.
As a medical imaging tool, the development of this AI program by the NHS marks a significant milestone.
The UK government has been investing in NHS AI projects, recognizing their potential to transform healthcare.
AI technology helps accelerate the diagnostic process, aid in early disease detection, and ultimately improve patient outcomes.
It is important to emphasize that AI should not be seen as a substitute for highly trained medical professionals.
Instead, it is a valuable tool that complements their expertise, enabling them to provide more efficient and accurate care.
The introduction of AI technology in cancer radiotherapy represents a major breakthrough, effectively reducing waiting time for patients and simplifying the treatment planning process.
As the NHS provides this cutting-edge technology to all NHS trusts at cost price, its benefits will extend to a larger population.
While AI continues to evolve and play a crucial role in healthcare, healthcare professionals remain indispensable in providing personalized and specialized care.
The integration of AI with clinical expertise creates a powerful force that has the potential to transform patient care and improve treatment outcomes.
Source: https://aimagazine.com/articles/ai-breakthrough-in-cancer-radiotherapy-treatment-time
Alphabet Q1 paid subscribers reached 350M, fueled by YouTube & Google One. YouTube ad revenue slightly missed at $9.88B amid Premium growth. Total Q1 revenue hit $109.9B, beating forecasts.
Anthropic releases Claude connectors for Adobe, Blender, and Ableton, enabling AI workflow automation and app control. It also sponsors the Blender Development Foundation.
Apple introduces an App Store model splitting 12-month plans into monthly installments. On iOS 26.4+, it lowers upfront costs without reducing total price, adding billing tracking.
Google launches Aadhaar digital IDs in Wallet for India, enabling secure QR/NFC verification. A phased partner rollout targets key sectors, while passport-based credentials expand globally.
YouTube tests "Ask YouTube," an AI tool blending text and video for complex queries. Initially for US Premium users, it supports interactive follow-ups, expanding Google's AI search.
Google grants US DoD classified AI access, joining OpenAI and xAI in defense deals amid Anthropic's dispute. Contractual safeguards against surveillance and lethal weapons remain unenforceable.
Mistral AI launches Workflows, a Temporal-powered orchestration platform for secure, Python-driven enterprise AI automation featuring human-in-the-loop approvals.